As of 3:57pm ET
| +0.01 / +1.69%|
The 2 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.30, with a high estimate of 3.00 and a low estimate of 1.60. The median estimate represents a +283.33% increase from the last price of 0.60.
The current consensus among 2 polled investment analysts is to Buy stock in Aveo Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.